Noelia Martínez-Jáñez

机构：Instituto Cajal, Hospital Universitario Ramón y Cajal · ORCID：0000-0002-0436-0906

发表论文 224 篇 · 总被引 3661 次 · h-index 27

代表论文

• VP1-2025: Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in previously-treated inoperable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2–) breast cancer (BC): Final overall survival (OS) from the phase III TROPION-Breast01 trial (2025 · Annals of Oncology · 被引 18)
• Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2− Highly Proliferative Breast Cancer (2025 · Clinical Cancer Research · 被引 4)
• Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations (2025 · npj Precision Oncology · 被引 3)
• Results of a phase 1 study of vosilasarm (EP0062), a first-in-class oral selective androgen receptor modulator (SARM) in patients with advanced or metastatic AR+/ER+/HER-2- breast cancer. (2025 · Journal of Clinical Oncology · 被引 2)
• GLP-1 receptor expression in a molecularly characterized cohort of endometrial carcinoma: Results from the GEICO 163-T/SPECTRUM study. (2026 · Journal of Clinical Oncology · 被引 1)
• Eribulin-induced pulmonary toxicity mimicking metastatic lung disease (2025 · Medicina Clínica · 被引 1)